Based in Eden Prairie, Minnesota, ACIST Medical Systems, part of the Bracco Group, was founded by an interventional cardiologist on a mission.
Dr. Robert (Bob) F. Wilson, Professor of Medicine and Director of the Interventional Cardiology Program at the University of Minnesota, wanted to create a device that took into consideration the needs of both physicians and patients in the cath lab. This sparked the creation of ACIST CVi™, a device that simplifies contrast injection for all procedures.
Since then, ACIST has become a knowledge catalyst, helping interventional cardiologists quickly visualize, assess and improve patient treatment.
Bracco is an international Group active in the healthcare sector and a leader in diagnostic imaging. It has around 3,420 employees and annual total consolidated revenues of around 1,29 billion euros, 86% of which from international sales. The Bracco diagnostic imaging product portfolio is completed by medical devices and advanced imaging agents injection systems.
Bracco Injeneering is a company committed to developing the best-in-class integrated injection solutions with a strong heritage in research and innovation. It provides quality solutions for state-of-the-art radiology centers, offering proven injection technology, built on Bracco
Imaging expertise. The product portfolio includes CT Exprès, EmpowerCTA®, EmpowerMR® and Nexo. Bracco Imaging continues to be focused on constant innovation, not only for devices, but also for software development and data management.
To submit a grant request to ACIST Medical systems please fill out the Grant Request Form and submit to the ACIST Grants Team at email@example.com. All grant requests must be received 60 days prior to the date of the event or project due date.
Through our relentless commitment to innovation, we optimize interventional decisions, equipping people with the power to get back to life.
BMT New Operational Footprint
ACIST – BINJ Harmonization Process
Organizational Alignment for Bracco Medical Technologies: ACIST-BINJ-HLT
Bracco Injeneering SA acquired the business segment (patents and trademarks inclusive) for CT/MR injectors from ACIST. CTA+ manufacturing continues at ACIST
Acquisition of Silicon Valley Medical Instruments
Acquisition of Swiss Medical Care, company based in Lausanne active in research, production and marketing of automatic contrast agent delivery systems. Now Bracco Injeneering SA.
Acquisition of E-Z-EM
Acquisition E-Z-EM, leading manufacturer of contrast agents for gastrointestinal radiology. The Company also offers the first family of CT/MR injectors. Injectors business owned and manufactured by ACIST
Acquisition ACIST Medical System Inc, a global leader in the contrast agent injection systems for cardiology.
Products available in more than 60 countries
Employs 400+ people worldwide
Here at ACIST we pride ourselves on being an active member in our local communities by giving back and supporting several nonprofits that help better society. We empower our team to champion efforts to improve the lives of others.
President, Chief Executive Officer
Vice President, Diagnostic Imaging Product Development
Senior Vice President, Research & Development
Vice President, Quality Assurance
Vice President, Finance
Vice President of Sales, EMEA
Vice President, General Counsel & Secretary
Vice President, Cardiovascular Product Development
Sr. Vice President General Manager, Cardiovascular Devices
Vice President, Human Resources
Vice President, Regulatory & Clinical Affairs
Vice President of Sales, Americas
ACIST Japan President
Vice President, Global Operations & Service
7905 Fuller Road
Eden Prairie, Minnesota 55344
Phone: 952-995-9300 or 888-667-6648
47621 Westinghouse Drive
Fremont, California 94539
7F Dainippon-Tosho Otsuka
3-Chrome Bldg. 3-11-6, Otsuka
Bunkyo-Ku, Tokyo 112-0012
Phone: +81 369029520
ACIST can help with peripheral, cardiovascular disease and structural procedures.
Contact a rep to learn more about ACIST products.